🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Verapamil is an L-type calcium channel blocker(CCB) which has been shown to...
Status
Terminated
Location
Massachusetts Eye and Ear
Start Date
2017-06-05
Trial ID
NCT03102190
Treatments Being Tested
The goal of this clinical trial is to learn whether intravenous verapamil o...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2027-01-01
Trial ID
NCT07706075
Treatments Being Tested
The purpose of this study is to determine the bioequivalency of Synerx Phar...
Status
Completed
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT01467687
Treatments Being Tested
The objective for this study was to investigate the bioequivalence of Mylan...
Status
Completed
Location
PRACS Institute, Ltd.
Start Date
2006-01
Trial ID
NCT00648401
The purpose of this study is to examine the drug-drug interaction when give...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2017-09-27
Trial ID
NCT03296800
Treatments Being Tested
The purpose of this extension study is to continue to follow the participan...
Status
Unknown
Location
Stanford University
Start Date
2021-05-07
Trial ID
NCT06177691
The objective of this study was to investigate the bioequivalence of Mylan'...
Status
Completed
Location
PRACS Institute, Ltd.
Start Date
2006-01
Trial ID
NCT00649805
Unwanted effects on the cardiovascular system is one of the most common cau...
Status
Terminated
Location
Addenbrooke's Hospital
Start Date
2017-04-24
Trial ID
NCT03098680
The objective for this study was to investigate the bioequivalence of Mylan...
Status
Completed
Location
PRACS Institute, Ltd.
Start Date
2006-03
Trial ID
NCT00648050
The investigators are conducting a pilot open-label pre/post interventional...
Status
Not Yet Recruiting
Location
Diabetes Research Center, Massachusetts General Hospital
Start Date
2026-08-01
Trial ID
NCT07688070
Treatments Being Tested